We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$8.72B
AUM Growth
+$530M
Cap. Flow
+$148M
Cap. Flow %
1.7%
Top 10 Hldgs %
28.95%
Holding
403
New
16
Increased
188
Reduced
143
Closed
14

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$84.7M
2
XOM icon
ExxonMobil
XOM
+$52.3M
3
ADI icon
Analog Devices
ADI
+$51.3M
4
KMB icon
Kimberly-Clark
KMB
+$48.2M
5
SJM icon
J.M. Smucker
SJM
+$48.2M

Top Sells

Rank Stock Value
1
SE
Spectra Energy Corp Wi
SE
+$147M
2
TGT icon
Target
TGT
+$54.3M
3
KO icon
Coca-Cola
KO
+$52.1M
4
TXN icon
Texas Instruments
TXN
+$46M
5
ABT icon
Abbott
ABT
+$42.1M

Sector Composition

Rank Sector Weight
1 Technology 16.91%
2 Healthcare 15.12%
3 Consumer Staples 14.29%
4 Financials 13.81%
5 Industrials 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNRO icon
276
Monro
MNRO
$383M
$796K 0.01%
15,280
+1,640
+12% +$93K
ATRI
277
DELISTED
Atrion Corp
ATRI
$796K 0.01%
1,700
+200
+13% +$95.1K
CAT icon
278
Caterpillar
CAT
$375B
$782K 0.01%
8,434
+73
+0.9% +$6.91K
IVV icon
279
iShares Core S&P 500 ETF
IVV
$884B
$747K 0.01%
3,149
-316
-9% -$73.9K
GLD icon
280
SPDR Gold Trust
GLD
$131B
$746K 0.01%
6,280
+81
+1% +$9.42K
GSK icon
281
GSK
GSK
$104B
$731K 0.01%
13,865
-120
-0.9% -$6.09K
FORR icon
282
Forrester Research
FORR
$223M
$723K 0.01%
18,180
+7,515
+70% +$295K
FUN icon
283
Cedar Fair
FUN
$1.77B
$716K 0.01%
10,558
-100
-0.9% -$6.57K
PETS icon
284
PetMed Express
PETS
$41.7M
$710K 0.01%
35,230
+740
+2% +$15.7K
MON
285
DELISTED
Monsanto Co
MON
$708K 0.01%
6,254
-1,174
-16% -$130K
SCL icon
286
Stepan Co
SCL
$1.46B
$697K 0.01%
8,845
+990
+13% +$77.3K
SRE icon
287
Sempra
SRE
$57.9B
$694K 0.01%
12,550
+70
+0.6% +$3.72K
COST icon
288
Costco
COST
$422B
$690K 0.01%
4,114
+36
+0.9% +$6.03K
HY icon
289
Hyster-Yale Materials Handling
HY
$599M
$689K 0.01%
12,219
+1,385
+13% +$84K
TMO icon
290
Thermo Fisher Scientific
TMO
$213B
$688K 0.01%
4,482
+42
+0.9% +$6.42K
HPE icon
291
Hewlett Packard
HPE
$63.4B
$678K 0.01%
49,266
+96
+0.2% +$1.29K
WM icon
292
Waste Management
WM
$90.6B
$677K 0.01%
9,288
-332
-3% -$23.7K
SNN icon
293
Smith & Nephew
SNN
$13.3B
$661K 0.01%
21,380
-60
-0.3% -$1.84K
IEMG icon
294
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
$660K 0.01%
13,815
GBCI icon
295
Glacier Bancorp
GBCI
$6.42B
$649K 0.01%
19,143
+2,135
+13% +$75.6K
EXR icon
296
Extra Space Storage
EXR
$31.3B
$643K 0.01%
8,646
+350
+4% +$26.4K
EEM icon
297
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$637K 0.01%
16,180
-882
-5% -$33.5K
IFF icon
298
International Flavors & Fragrances
IFF
$20.2B
$617K 0.01%
4,652
SU icon
299
Suncor Energy
SU
$79.4B
$617K 0.01%
20,044
-7,211
-26% -$227K
COR icon
300
Cencora
COR
$60.6B
$608K 0.01%
6,865
-1,173
-15% -$103K

Similar funds

Bahl & Gaynor's Q1 2017 Portfolio in Review

As of Q1 2017, Bahl & Gaynor held 403 positions worth $8.72B, up 6.5% from $8.19B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bahl & Gaynor's Q1 2017 filing shows 16 new, 188 increased, 143 reduced and 14 closed positions. Its largest new stake was California Resources Corporation: 63,538 shares worth $956K. The largest sale was Spectra Energy Corp Wi, an estimated $147M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Bahl & Gaynor's largest Q1 2017 buy was California Resources Corporation: 63,538 shares worth $956K.
  • Bahl & Gaynor added most to Enbridge in Q1 2017, an estimated $84.7M increase.
  • Bahl & Gaynor's biggest Q1 2017 reduction was Target, cutting an estimated $54.3M.
  • Bahl & Gaynor fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $147M.
  • Bahl & Gaynor's ten largest holdings make up 29% of its $8.72B portfolio in Q1 2017.
  • Bahl & Gaynor opened 16 new positions and closed 14 in Q1 2017.
  • Bahl & Gaynor's portfolio value rose 6.5% quarter-over-quarter to $8.72B.

Based on Bahl & Gaynor's 13F filing for Q1 2017, filed 9 May 2017.